New Drug Application Custom Crystal

Get a Design QuicklyFAQs
New Drug Application Custom Crystal

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
FDA Application Crystal Commemorative

FDA Application Crystal Commemorative

Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches. (20ALJ356)

DAVID TAYLOR DIGITAL | DIGITAL MARKETING AGENCY